Pharmaceutical Executive February 8, 2024
Faruk Capan

EVERSANA’s chief innovation discusses his experience with Apple’s new device and how he thinks it might impact the life sciences industry.

In the ever-evolving landscape of augmented reality (AR), Apple’s recent launch of the Apple Vision Pro has undeniably set new benchmarks. As someone who has dipped his toes into the immersive world of AR across various devices, my initial experiences with the Apple Vision Pro have been met with a balanced mix of anticipation and skepticism.

So, what has this experience been like and what might this type of product mean to the healthcare and life sciences sector? Here’s my take.

A Leap Towards New AR Technology

From the moment...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Metaverse/VR, Pharma / Biotech, Technology
What’s next for smart glasses
AI is Driving a Smart Glasses Boom. Will It Last?
AI-Powered Digital Therapeutics Transform Neurocare for Parkinson's
Virtual reality in MRI guided radiation therapy
Meta Quest 3 Review: Mixed Reality For The Win

Share This Article